NCT03387852 Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants Status COMPLETED Phase PHASE2
NCT03382587 Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients Status COMPLETED Phase N/A
NCT03379558 Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study Status TERMINATED Phase N/A
NCT03359356 Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT03346434 Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) Status COMPLETED Phase PHASE2/PHASE3
NCT03345914 Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT03344692 Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03304379 Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip Status COMPLETED Phase PHASE3
NCT03294083 A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03293030 Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT03285646 Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee Status TERMINATED Phase PHASE3
NCT03278262 The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting Status COMPLETED Phase N/A
NCT03233139 Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03198130 An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1) Status COMPLETED Phase PHASE1
NCT03188666 A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva Status COMPLETED Phase PHASE2
NCT03175367 Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT03161912 A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease Status COMPLETED Phase N/A